Pandonia ApS – Trademark Portfolio

Entity Type: 66

Pandonia ApS holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PANDONIA.

Classensgade 25A

DK-2100 København Ø

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PANDONIA
PANDONIA
Registered 2021

Trademark Classifications

Pandonia ApS's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Pandonia ApS have?

Pandonia ApS has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Pandonia ApS file in?

Pandonia ApS files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Pandonia ApS's most well-known trademarks?

Pandonia ApS's registered trademark portfolio includes well-known marks such as PANDONIA. These are among 1 currently registered trademark in the portfolio.

What is Pandonia ApS's trademark registration success rate?

Pandonia ApS has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.